These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 35124731)

  • 21. Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis.
    Srivastava A; Nogueras Gonzalez GM; Geng Y; Won AM; Cabanillas ME; Naing A; Myers JN; Li Y; Chambers MS
    Support Care Cancer; 2021 May; 29(5):2305-2317. PubMed ID: 33190182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
    Ruggiero SL
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Prevention of Medication-related Osteonecrosis of the Jaw.
    Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
    Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: A systematic review with meta-analyses.
    Karna H; Gonzalez J; Radia HS; Sedghizadeh PP; Enciso R
    Oral Oncol; 2018 Oct; 85():15-23. PubMed ID: 30220314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication-related Osteonecrosis of the Jaw Induced by Regenerative Therapy in Implant Dentistry: A Scoping Review.
    Al-Omari FA; Kuroshima S; Sawase T
    J Dent; 2023 Nov; 138():104682. PubMed ID: 37708930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
    Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
    Lazarovici TS; Mesilaty-Gross S; Vered I; Pariente C; Kanety H; Givol N; Yahalom R; Taicher S; Yarom N
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Management of medication-related osteonecrosis of the jaw-a review of recent study results in comparison to established strategies].
    Tröltzsch M; Tröltzsch M; Pautke C; Otto S
    HNO; 2022 Jul; 70(7):499-507. PubMed ID: 35050392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Malignant Diseases and Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis.
    Yao S; Ding X; Rong G; Zhou J; Zhang B
    J Craniofac Surg; 2023 Mar-Apr 01; 34(2):669-673. PubMed ID: 36184756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid.
    Wei LY; Kok SH; Lee YC; Chiu WY; Wang JJ; Cheng SJ; Chang HH; Lee JJ
    J Formos Med Assoc; 2021 Aug; 120(8):1572-1580. PubMed ID: 33309430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw.
    Hayashida S; Yanamoto S; Fujita S; Hasegawa T; Komori T; Kojima Y; Miyamoto H; Shibuya Y; Ueda N; Kirita T; Nakahara H; Shinohara M; Kondo E; Kurita H; Umeda M
    J Bone Miner Metab; 2020 Jan; 38(1):126-134. PubMed ID: 31410544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
    Kawahara M; Kuroshima S; Sawase T
    Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
    Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
    J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study.
    Sakamoto Y; Sawada S; Kojima Y
    Sci Rep; 2023 Aug; 13(1):12890. PubMed ID: 37558709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents - A retrospective study of 240 patients.
    Coropciuc R; Coopman R; Garip M; Gielen E; Politis C; Van den Wyngaert T; Beuselinck B
    Bone; 2023 May; 170():116722. PubMed ID: 36858337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and risk factors of medication-related osteonecrosis of the jaw in osteoporotic and breast cancer patients: a cross-sectional study.
    Soares AL; Simon S; Gebrim LH; Nazário ACP; Lazaretti-Castro M
    Support Care Cancer; 2020 May; 28(5):2265-2271. PubMed ID: 31468192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex difference in the morbidity and pain response with stage 0 of medication-related osteonecrosis of the jaws.
    Zhang W; Gao R; Cui Y; Ding F; Zhu S; Luo S; Liu H; Li M
    J Oral Biosci; 2023 Dec; 65(4):324-333. PubMed ID: 37543255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part I: biological concepts with a review of the literature.
    Lee CY; Suzuki JB
    Implant Dent; 2009 Dec; 18(6):492-500. PubMed ID: 20009603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study.
    Kajizono M; Sada H; Sugiura Y; Soga Y; Kitamura Y; Matsuoka J; Sendo T
    Biol Pharm Bull; 2015; 38(12):1850-5. PubMed ID: 26632176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.